The latest product falling victim to supply chain issues is sparking major concerns among health practitioners

The latest product falling victim to supply chain issues is sparking major concerns among health practitioners

by

Disclaimer!:

Do you find yourself overwhelmed by financial trouble? Are you paying too much in debt payments, but can’t afford an unsecure high interest debt consolidation loan? Get a small business loan or personal loan and combine it with our debt consolidation services. At Quick Debt Consolidation Loans we offer quick, affordable debt relief for both individuals and small businesses. We’ll help you get the life you deserve – today!

In this article, you will get all the information regarding The latest product falling victim to supply chain issues is sparking major concerns among health practitioners

Popular medications, including a leading ADHD treatment, are the latest products to fall victim to the supply crunch in Australia.

According to the Therapeutic Goods Administration (TGA), Ritalin as well as some antidepressants and high blood pressure medications are all in short supply across the country.

Watch more in the video above

For more Medicine related news and videos check out Medicine >>

The medicines regulator listed dozens of medications that are in short supply on Thursday, with 343 medicines currently facing shortages.

A supplier of the popular ADHD treatment, Ritalin (methylphenidate) also confirmed Australia has seen a shortage of the supply, but added it is being addressed.

Supplier Novartis Pharmaceuticals Australia told Ilmhunt.com.au the shortage was due to a manufacturing issue that has now been resolved.

The popular medications have been in short supply across the country amid a supply chain crunch. Credit: ullstein bild/ullstein bild via Getty Images

“Novartis is aware of the temporary shortage of Ritalin (methylphenidate) long acting tablets in 10mg, 20mg, 30mg, 40mg and 60mg within Australia,” it said.

“We are working closely with suppliers to resolve the supply issue as quickly as possible.”

“We recommend consumers currently on this treatment, speak with their healthcare professional if they have any questions or to seek alternative treatment options.”

The Australian Association of Psychologists Inc (AAPi) Executive Director Tegan Carrison told Ilmhunt.com.au: “The Australian Association of Psychologists is concerned about reports of shortages of mental health medications.”

“We would encourage patients to discuss any concerns about medication shortages with their treating health professional.”

Ilmhunt.com.au has reached out to the Therapeutic Goods Administration for further comment.

If you’d like to view this content, please adjust your .

To find out more about how we use cookies, please see our Cookie Guide.

The latest product falling victim to supply chain issues is sparking major concerns among health practitioners

For more visit IlmHunt.com

Latest News by IlmHunt.com

Spread the love

Leave a Reply

Your email address will not be published.